Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
10 2020
Historique:
received: 22 04 2020
revised: 08 06 2020
accepted: 10 06 2020
pubmed: 23 6 2020
medline: 2 10 2020
entrez: 23 6 2020
Statut: ppublish

Résumé

To survey healthcare workers (HCW) on availability and use of personal protective equipment (PPE) caring for COVID-19 patients in the intensive care unit (ICU). A web-based survey distributed worldwide in April 2020. We received 2711 responses from 1797 (67%) physicians, 744 (27%) nurses, and 170 (6%) Allied HCW. For routine care, most (1557, 58%) reportedly used FFP2/N95 masks, waterproof long sleeve gowns (1623; 67%), and face shields/visors (1574; 62%). Powered Air-Purifying Respirators were used routinely and for intubation only by 184 (7%) and 254 (13%) respondents, respectively. Surgical masks were used for routine care by 289 (15%) and 47 (2%) for intubations. At least one piece of standard PPE was unavailable for 1402 (52%), and 817 (30%) reported reusing single-use PPE. PPE was worn for a median of 4 h (IQR 2, 5). Adverse effects of PPE were associated with longer shift durations and included heat (1266, 51%), thirst (1174, 47%), pressure areas (1088, 44%), headaches (696, 28%), Inability to use the bathroom (661, 27%) and extreme exhaustion (492, 20%). HCWs reported widespread shortages, frequent reuse of, and adverse effects related to PPE. Urgent action by healthcare administrators, policymakers, governments and industry is warranted.

Identifiants

pubmed: 32570052
pii: S0883-9441(20)30592-X
doi: 10.1016/j.jcrc.2020.06.005
pmc: PMC7293450
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-75

Subventions

Organisme : Wellcome Trust
ID : 205214/Z/16/Z
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr. Tabah has nothing to disclose, Dr. Ramanan has nothing to disclose, Prof. Laupland has nothing to disclose, Dr. Buetti has nothing to disclose, Dr. Cortegiani has nothing to disclose, Mr. Mellinghoff has nothing to disclose, Dr. Conway Morris reports grants from Wellcome Trust, during the conduct of the study; Dr. Camporota has nothing to disclose, Dr. Zappella has nothing to disclose, Dr. Vidal has nothing to disclose, Dr. Elhadi has nothing to disclose, Dr. Povoa reports personal fess from Orion, personal fees from Pfizer and personal fees from Technofage, Dr. Amrein reports grants, personal fees and other from Fresenius Kabi, personal fees from Vifor Pharma, personal fees from Shire now part of Takeda, outside the submitted work, Dr. Derde reports grants from European Union, grants from ZonMw, outside the submitted work, Guy Francoishas nothing to disclose, Dr. Bassetti reports grants and personal fees from Pfizer, grants and personal fees from MSD, grants and personal fees from Menarini, grants and personal fees from Angelini, personal fees from Astellas, personal fees from Nabriva, grants and personal fees from Paratek, personal fees from Gilead, personal fees from Basilea, personal fees from Cidara, personal fees from Molteni, outside the submitted work; Dr. Ssi Yan Kai has nothing to disclose, Dr. De Waelereports grants from Research Foundation Flanders, during the conduct of the study; other from Bayer, other from Pfizer, other from MSD, other from Grifols, other from Accelerate, outside the submitted work;.

Références

Emerg Infect Dis. 2020 Jul;26(7):1583-1591
pubmed: 32275497
BMJ. 2020 Apr 3;369:m1367
pubmed: 32245847
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Can J Anaesth. 2020 May;67(5):568-576
pubmed: 32052373
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Cochrane Database Syst Rev. 2020 Apr 15;4:CD011621
pubmed: 32293717
JAMA. 2020 May 19;323(19):1915-1923
pubmed: 32275295
N Engl J Med. 2020 Apr 30;382(18):e41
pubmed: 32212516
Anaesthesia. 2020 Aug;75(8):1121-1122
pubmed: 32496625
PLoS One. 2019 Jan 22;14(1):e0210775
pubmed: 30668567
JAMA. 2020 Jun 2;323(21):2133-2134
pubmed: 32259193

Auteurs

Alexis Tabah (A)

Intensive Care Unit, Faculty of Medicine, Redcliffe Hospital, University of Queensland, 4019, Redcliffe, Brisbane, Queensland 4029, Australia. Electronic address: a.tabah@uq.edu.au.

Mahesh Ramanan (M)

Intensive Care Units, Caboolture and Prince Charles Hospitals, School of Medicine, University of Queensland, The George Institute for Global Health, University of New South Wales, Sydney, Queensland, Australia.

Kevin B Laupland (KB)

Department of Intensive Care Services, Royal Brisbane and Women's Hospital, Queensland University of Technology, Brisbane, Queensland, Australia.

Niccolò Buetti (N)

INSERM IAME, U1137, Team DesCID, Paris, France.

Andrea Cortegiani (A)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.) Section of Anesthesia, Analgesia, Intensive Care and Emergency Policlinico Paolo Giaccone University of Palermo Palermo, Italy.

Johannes Mellinghoff (J)

Faculty of Health and Social Care Education, Kingston & St George's University of London, UK.

Andrew Conway Morris (A)

Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK.

Luigi Camporota (L)

Centre for Human & Applied Physiological Sciences (CHAPS) and School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, Department of Critical Care, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Nathalie Zappella (N)

Anesthesiology and Critical Care Medicine Department, DMU PARABOL, Bichat - Claude Bernard Hospital, HUPNVS, AP-HP, Paris, France.

Muhammed Elhadi (M)

Faculty of Medicine, University of Tripoli, Libya.

Pedro Povoa (P)

Sao Francisco Xavier Hospital, CHLO, NOVA Medical School, CHRC, New University of Lisbon, Lisbon, Portugal.

Karin Amrein (K)

Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Gabriela Vidal (G)

Servicio de Terapia Intensiva, Hospital Interzonal de Agudos San Martin de La Plata, La Plata, Buenos Aires, Argentina.

Lennie Derde (L)

Intensive Care Center, University Medical Center Utrecht, Utrecht, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

Matteo Bassetti (M)

Infectious Diseases Clinic, Department of Health Sciences, University of Genoa, Genoa and Hospital Policlinico San Martino-IRCCS, Genoa, Italy.

Guy Francois (G)

Division of Scientific Affairs, Research, European Society of Intensive Care Medicine, Brussels, Belgium.

Nathalie Ssi Yan Kai (N)

Brisbane, Australia.

Jan J De Waele (JJ)

Department of Critical Care Medicine, Ghent University Hospital, Gent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH